Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Expert Ratings for Frontdoor

Frontdoor (NASDAQ:FTDR) has observed the following analyst ratings within the last quarter:

Benzinga

Earnings Preview For Petco Health and Wellness

Petco Health and Wellness (NASDAQ:WOOF) is set to give its latest quarterly earnings report on Tuesday, 2022-05-24. Here's what investors need to know before the announcement. Analysts estimate that Petco Health and Wellness will report an earnings per share (EPS) of $0.16.

Benzinga

Analyst Ratings for Amgen

Analysts have provided the following ratings for Amgen (NASDAQ:AMGN) within the last quarter:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Analyst Ratings for Bicycle Therapeutics

Bicycle Therapeutics (NASDAQ:BCYC) has observed the following analyst ratings within the last quarter:

Benzinga

NMI Holdings's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, NMI Holdings (NASDAQ:NMIH) earned $67.68 million, a 11.82% increase from the preceding quarter. NMI Holdings also posted a total of $127.44 million in sales, a 1.89% increase since Q4.

Benzinga

Inari Medical's Return On Capital Employed Insights

Benzinga Pro data, Inari Medical (NASDAQ:NARI) reported Q1 sales of $86.75 million. Earnings fell to a loss of $3.13 million, resulting in a 382.66% decrease from last quarter.

Benzinga

PetIQ's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, PetIQ (NASDAQ:PETQ) earned $3.16 million, a 121.83% increase from the preceding quarter. PetIQ also posted a total of $275.69 million in sales, a 40.21% increase since Q4.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Looking Into Open Text's Return On Capital Employed

Pulled from Benzinga Pro data, Open Text (NASDAQ:OTEX) showed a loss in earnings since Q2, totaling $74.72 million. Sales, on the other hand, increased by 0.63% to $882.28 million during Q3.

Benzinga

Heritage-Crystal Clean's Return On Capital Employed Insights

Pulled from Benzinga Pro data, Heritage-Crystal Clean (NASDAQ:HCCI) posted Q1 earnings of $12.88 million, an increase from Q4 of 28.94%. Sales dropped to $139.37 million, a 17.78% decrease between quarters.

Benzinga

DLH Holdings's Return on Invested Capital Overview

Pulled from Benzinga Pro data, DLH Holdings (NASDAQ:DLHC) posted Q2 earnings of $7.18 million, an increase from Q1 of 8.02%. Sales dropped to $108.70 million, a 28.86% decrease between quarters.

Benzinga

Looking Into RMR Group's Return On Invested Capital

According to Benzinga Pro data RMR Group (NASDAQ:RMR) posted a 20.24% decrease in earnings from Q1. Sales, however, increased by 8.86% over the previous quarter to $197.65 million.

Benzinga

What's Going On With Farmmi Shares Today?

Farmmi Inc (NASDAQ: FAMI) shares are trading lower by 4.11% at around $0.08.

Benzinga

Short Volatility Alert: RAVE Restaurant Group

On Friday, shares of RAVE Restaurant Group, Inc. (NASDAQ: RAVE) experienced volatile short activity. After the activity, the stock price went down -1.07% to $0.876. The overall sentiment for RAVE has been Bearish.

Benzinga

Short Volatility Alert: Vidler Water Resources

On Friday, shares of Vidler Water Resources, Inc. (NASDAQ: VWTR) experienced volatile short activity. After the activity, the stock price went up 0.19% to $15.75. The overall sentiment for VWTR has been Bullish.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Short Volatility Alert: PetMed Express

On Friday, shares of PetMed Express (NASDAQ: PETS) experienced volatile short activity. After the activity, the stock price went down -1.19% to $19.95. The overall sentiment for PETS has been Bearish.

Benzinga

What 6 Analyst Ratings Have To Say About Xcel Energy

Within the last quarter, Xcel Energy (NASDAQ:XEL) has observed the following analyst ratings:

Benzinga

4 Analysts Have This to Say About MGE Energy

MGE Energy (NASDAQ:MGEE) has observed the following analyst ratings within the last quarter:

Benzinga

Canadian Solar's Earnings: A Preview

Canadian Solar (NASDAQ:CSIQ) is set to give its latest quarterly earnings report on Tuesday, 2022-05-24. Here's what investors need to know before the announcement. Analysts estimate that Canadian Solar will report an earnings per share (EPS) of $-0.13.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

eBay Launches NFT Collection In Partnership With OneOf

eBay Inc (NASDAQ:EBAY) has launched a series of NFTs through a strategic partnership with OneOf, a green NFT platform for communities across music, sports, and lifestyle. The partnership combines eBay's global reach and inventory and OneOf's eco-conscious Web3 technology. eBay's first Genesis NFT Collection will feature 3D and animated interpretations of athletes featured…

Benzinga

If You Invested $100 In TSLA 10 Years Ago, Here's How Much You Would Have Today

Tesla (NASDAQ:TSLA) has outperformed the market over the past 10 years by 47.64% on an annualized basis producing an average annual return of 59.02%. Currently, Tesla has a market capitalization of $679.55 billion.

Benzinga

Looking Into Sovos Brands's Return On Invested Capital

According to Benzinga Pro, during Q1, Sovos Brands (NASDAQ:SOVO) earned $4.06 million, a 205.65% increase from the preceding quarter. Sovos Brands also posted a total of $209.93 million in sales, a 10.93% increase since Q4.

Benzinga

Aligos Therapeutics's Return On Capital Employed Insights

According to Benzinga Pro data, during Q1, Aligos Therapeutics (NASDAQ:ALGS) posted sales of $2.57 million. Earnings were up 5.57%, but Aligos Therapeutics still reported an overall loss of $35.62 million.

Benzinga

Looking Into Liberty Latin America's Return On Invested Capital

According to Benzinga Pro, during Q1, Liberty Latin America (NASDAQ:LILA) earned $93.20 million, a 114.24% increase from the preceding quarter. Liberty Latin America's sales decreased to $1.22 billion, a 4.69% change since Q4.

Benzinga

Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer

Seagen Inc (NASDAQ:SGEN) announced topline results from phase 2 MOUNTAINEER trial investigating Tukysa (tucatinib) in combination with trastuzumab in previously treated HER2-positive metastatic colorectal cancer (mCRC) patients. Trastuzumab is sold under the name Herceptin by Genentech, a unit of Roche Holdings AG (OTC:RHHBY). Data from this trial will form the basis of a planned supplemental…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022

1 … 428 429 430 431

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.